The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vollmer, T. L.
Right arrow Articles by Shi, F.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vollmer, T. L.
Right arrow Articles by Shi, F.-D.
The Journal of Immunology, 2005, 174: 2696-2701.
Copyright © 2005 by The American Association of Immunologists

Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen1

Timothy L. Vollmer*, Ruolan Liu*, Mary Price*, Susan Rhodes*, Antonio La Cava{dagger} and Fu-Dong Shi2,*

* Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013; and {dagger} Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095

The cytokine IL-21 is closely related to IL-2 and IL-15, a cytokine family that uses the common {gamma}-chain for signaling. IL-21 is expressed by activated CD4+ T cells. We examined the role of IL-21 in the autoimmune disease experimental autoimmune encephalomyelitis (EAE), an animal model for human multiple sclerosis. IL-21 administration before induction of EAE with a neuroantigen, myelin oligodendrocyte glycoprotein peptide 35-55, and adjuvant enhanced the inflammatory influx into the CNS, as well as the severity of EAE. Autoreactive T cells purified from IL-21-treated mice transferred more severe EAE than did the control encephalitogenic T cells. No such effects were observed when IL-21 was administered after EAE progressed. Additional studies demonstrated that IL-21 given before the induction of EAE boosted NK cell function, including secretion of IFN-{gamma}. Depletion of NK cells abrogated the effect of IL-21. Therefore, IL-21, by affecting NK cells, has differential effects during the initiation and progression of autoimmune responses against neuroantigens.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Jang, S.-H. Cho, H. Park, D.-J. Paik, J. M. Kim, and J. Youn
A Positive Feedback Loop of IL-21 Signaling Provoked by Homeostatic CD4+CD25- T Cell Expansion Is Essential for the Development of Arthritis in Autoimmune K/BxN Mice
J. Immunol., April 15, 2009; 182(8): 4649 - 4656.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lunemann, J. D. Lunemann, S. Roberts, B. Messmer, R. B. da Silva, C. S. Raine, and C. Munz
Human NK Cells Kill Resting but Not Activated Microglia via NKG2D- and NKp46-Mediated Recognition
J. Immunol., November 1, 2008; 181(9): 6170 - 6177.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Lamprecht, S. Kreher, I. Anagnostopoulos, K. Johrens, G. Monteleone, F. Jundt, H. Stein, M. Janz, B. Dorken, and S. Mathas
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3{alpha}
Blood, October 15, 2008; 112(8): 3339 - 3347.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Ferrari-Lacraz, R. Chicheportiche, G. Schneiter, N. Molnarfi, J. Villard, and J.-M. Dayer
IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes
Int. Immunol., August 1, 2008; 20(8): 1009 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. De Sarno, R. C. Axtell, C. Raman, K. A. Roth, D. R. Alessi, and R. S. Jope
Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 2008; 181(1): 338 - 345.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. D. Lunemann and C. Munz
Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
Brain, July 1, 2008; 131(7): 1681 - 1683.
[Full Text] [PDF]


Home page
Int ImmunolHome page
T. Onoda, M. Rahman, H. Nara, A. Araki, K. Makabe, K. Tsumoto, I. Kumagai, T. Kudo, N. Ishii, N. Tanaka, et al.
Human CD4+ central and effector memory T cells produce IL-21: effect on cytokine-driven proliferation of CD4+ T cell subsets
Int. Immunol., October 1, 2007; 19(10): 1191 - 1199.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Caruso, D. Fina, I. Peluso, M. C. Fantini, C. Tosti, G. D. V. Blanco, O. A. Paoluzi, F. Caprioli, F. Andrei, C. Stolfi, et al.
IL-21 Is Highly Produced in Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases Synthesis
J. Immunol., May 1, 2007; 178(9): 5957 - 5965.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Herber, T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos
IL-21 Has a Pathogenic Role in a Lupus-Prone Mouse Model and Its Blockade with IL-21R.Fc Reduces Disease Progression
J. Immunol., March 15, 2007; 178(6): 3822 - 3830.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Coquet, K. Kyparissoudis, D. G. Pellicci, G. Besra, S. P. Berzins, M. J. Smyth, and D. I. Godfrey
IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production
J. Immunol., March 1, 2007; 178(5): 2827 - 2834.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Frohlich, B. J. Marsland, I. Sonderegger, M. Kurrer, M. R. Hodge, N. L. Harris, and M. Kopf
IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo
Blood, March 1, 2007; 109(5): 2023 - 2031.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Peluso, M. C. Fantini, D. Fina, R. Caruso, M. Boirivant, T. T. MacDonald, F. Pallone, and G. Monteleone
IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes
J. Immunol., January 15, 2007; 178(2): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Liu, L. V. Kaer, A. L. Cava, M. Price, D. I. Campagnolo, M. Collins, D. A. Young, T. L. Vollmer, and F.-D. Shi
Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease
J. Immunol., May 1, 2006; 176(9): 5247 - 5254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.